Who Paid My Doc
Peter Hwang
Otolaryngology Palo Alto, CA Medical Doctor
NPI 1629127428 CMS profile 28691
725 Welch Rd, Palo Alto, CA 94304
General payments
$90,164
Research payments
$0
Ownership & investment interest
$9,984
Research they led as principal investigator
$32,971
Through program year 2025, Peter Hwang of Palo Alto, CA is reported in the CMS Open Payments database as having received $90,164 across 52 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $32,971 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $9,984 across 1 holding.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 98th percentile of Otolaryngology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $448 | 7 | |
| 2024 | General | $5,395 | 7 | |
| 2023 | General | $6,219 | 6 | |
| 2022 | General | $13,994 | 17 | |
| 2021 | General | $31 | 1 | |
| 2020 | General | $6,641 | 5 | |
| 2019 | General | $57,437 | 9 | |
| 2021 | Ownership | $9,984 | 1 |
Beside peers
- Peter Hwang
- Otolaryngology median
- Middle half of Otolaryngology
- National median
In program year 2025, general payments to Peter Hwang were reported at $448. Among 6,588 Otolaryngology profiles paid that year, the median was $317 and the middle half received between $125 and $815.
Show as a table
| Year | Peter Hwang | Otolaryngology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $57,437 | $194 | $82–$512 | $163 |
| 2020 | $6,641 | $118 | $42–$280 | $114 |
| 2021 | $31 | $167 | $63–$444 | $132 |
| 2022 | $13,994 | $216 | $84–$545 | $149 |
| 2023 | $6,219 | $235 | $93–$588 | $160 |
| 2024 | $5,395 | $280 | $111–$699 | $164 |
| 2025 | $448 | $317 | $125–$815 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 51 billing codesPaid by Medicare
$110,868
Medicare patients
329
Services billed
937
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 64% | |
| Arthritis | 44% | |
| Diabetes | 22% | |
| Atrial fibrillation | 21% | |
| Osteoporosis | 21% | |
| Ischemic heart disease | 20% | |
| COPD | 19% | |
| Depression | 17% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
52 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Otolaryngology in California
Related records
Otolaryngology in California
Practitioners in the same specialty and state, ranked by reported value.
All Otolaryngology
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.